Table 3.
Factor | Univariable Model OR (95% CI) |
P Value | Multivariable Modelsa OR (95% CI) |
P Value |
---|---|---|---|---|
Transmission risk group MSM | 1 | |||
Heterosexual | 4.2 (1.7–10) | .002 | 3.5 (1.1–10) | .027 |
Intravenous drug use | 2.8 (1.2–6.5) | .014 | 1.9 (0.61–5.8) | .268 |
Age per 10 y | 0.84 (0.61–1.2) | .29 | 0.67 (0.43–1.0) | .073 |
Alcohol consumptionb | 3.0 (1.6–5.8) | .001 | 2.7 (1.3–5.7) | .008 |
Corticosteroid usec | 4.1 (1.4–12) | .009 | 3.4 (0.97–12) | .057 |
CD4 nadir <200 cells/µL | 1.9 (0.99–3.7) | .054 | 1.4 (0.63–3.2) | .392 |
Log10 maximal HIV-1 viral load | 3.6 (0.89–15) | .071 | 1.6 (0.41–6.6) | .491 |
Pancreatitis | 4.0 (1.0–16) | .05 | 3.0 (0.66–14) | .153 |
Hyperlipidemiad | 3.8 (1.6–9.0) | .002 | 3.6 (1.4–9.6) | .010 |
Smoking, >20 pack-years | 1.6 (0.94–2.8) | .081 | 1.2 (0.59–2.63) | .565 |
Testosterone use | 0.40 (0.09–1.8) | .237 | 0.38 (0.07–2.2) | .279 |
Abbreviations: CI, confidence interval; OR, odds ratio.
aMultivariable models were adjusted for transmission risk group, age, alcohol consumption, use of corticosteroids, CD4 nadir, maximum viral load, pancreatitis, hyperlipidemia, smoking, and testosterone use.
bAlcohol use: moderate (female 20–40 g/d, male 40–60 g/d) and severe use (female >40 g/d, male >60 g/).
cCorticosteroid intake for more than 3 months.
dHyperlipidemia: cholesterol >5 mmol/L and/or triglyceride >2 mmol/L.